Certain type of hormone therapy increases breast cancer risk, study finds
The study, published Tuesday in The Lancet Oncology, found that estrogen plus progesterone increases the risk of breast cancer in women under 55 with a uterus, while estrogen alone reduces the risk.
Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, told "CBS Mornings" Wednesday the study participants, all under age 55, were divided into two groups — women who still have their uterus and those who do not, since they require different types of treatment.
A hysterectomy is the surgical removal of the uterus, which may be done for a number of reasons, including abnormal vaginal bleeding, severe pelvic pain, uterine fibroids, severe endometriosis and certain types of cancer. Approximately 600,000 females get hysterectomies in the U.S. each year, according to the Cleveland Clinic.
"For the women who do still have a uterus, you have to give estrogen plus progesterone together. Estrogen alone will cause a thickening of the uterine lining, which can cause a different kind of cancer, what we call endometrial cancer. So you have to give the combination," Gounder said. "In women who no longer have a uterus, you can give estrogen alone."
And the difference in treatment mattered. "What they found is estrogen alone reduced the risk of breast cancer," she said. "There seems to be a slight increase in risk in breast cancer if you also took progesterone."
This research is a "great example of (how) science evolves," Gounder added.
It comes after an early 2000s study called the Women's Health Initiative that focused on older women who may not have started hormone replacement therapy until 10 or so years after going through menopause. The study, which raised safety concerns and led to a longtime public misunderstanding around hormone therapy, has since been found problematic in terms of how it was designed. Now healthcare professionals largely consider the treatment option safe and effective.
"The newer research is focused on what actually happens in real life, which is women who go through menopause in their 40s or 50s, (and) start treatment around that age," Gounder said.
As with most medications, hormone replacement therapy comes with certain risks for some people. The Mayo Clinic notes it can lead to increased risk of heart disease, stroke, blood clots and some cancers. In other cases, however, it can help reduce risk of cancer, prevent bone loss and reduce menopausal symptoms like hot flashes.
As the latest study shows, timing and type of hormone therapy can be crucial to potential outcomes, making it important that people consult their doctor and consider family history and other factors when considering treatment options.
Gounder said hormone replacement therapy is the most effective treatment for a lot of perimenopausal symptoms, and added, "You really need to sit down and talk to your doctor (to determine) what is the appropriate thing for you."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
23 minutes ago
- Forbes
ChatGPT As Your Bedside Companion: Can It Deliver Compassion, Commitment, And Care?
During the GPT-5 launch this week, Sam Altman, CEO of OpenAI, invited a cancer patient and her husband to the stage. She shared how, after receiving her biopsy report, she turned to ChatGPT for help. The AI instantly decoded the dense medical terminology, interpreted the findings, and outlined possible next steps. That moment of clarity gave her a renewed sense of control over her care. Altman mentioned; 'health is one of the top reasons consumers use ChatGPT, saying it 'empowers you to be more in control of your healthcare journey.' Around the world, patients are turning to AI chatbots like ChatGPT and Claude to better understand their diagnoses and take a more active role in managing their health. In hospitals, both patients and clinicians sometimes use these AI tools informally to verify information. At medical conferences, some healthcare professionals admit to carrying a 'second phone' dedicated solely to AI queries. Without accessing any private patient data, they use it to validate their assessments, much like patients seeking a digital 'second opinion' alongside their physician's advice. Even during leisure activities like hiking or camping, parents often rely on AI Chatbots like ChatGPT or Claude for quick guidance on everyday concerns such as treating insect bites or skin reactions in their children. This raises an important question: Can AI Companions Like ChatGPT, Claude, and Others Offer the Same Promise, Comfort, Commitment, and Care as Some Humans? As AI tools become more integrated into patient management, their potential to provide emotional support alongside clinical care is rapidly evolving. These chatbots can be especially helpful in alleviating anxiety caused by uncertainty, whether it's about a diagnosis, prognosis, or simply reassurance regarding potential next steps in medical or personal decisions. Given the existing ongoing stressors from disease management burden on patients, advanced AI companions like ChatGPT and Claude can play an important role by providing timely, 24/7 reassurance, clear guidance, and emotional support. Notably, some studies suggest that AI responses can be perceived as even more compassionate and reassuring than those from humans. Loneliness is another pervasive issue in healthcare. Emerging research suggests that social chatbots can reduce loneliness and social anxiety, underscoring their potential as complementary tools in mental health care. These advanced AI models help bridge gaps in information access, emotional reassurance, and patient engagement, offering clear answers, confidence, comfort, and a digital second opinion, particularly valuable when human resources are limited. Mustafa Suleyman, CEO of Microsoft AI, has articulated a vision for AI companions that evolve over time and transform our lives by providing calm and comfort. He describes an AI 'companion that sees what you see online and hears what you hear, personalized to you. Imagine the overload you carry quietly, subtly diminishing. Imagine clarity. Imagine calm.' While there are many reasons AI is increasingly used in healthcare, a key question remains: Why Are Healthcare Stakeholders Increasingly Turning to AI? Healthcare providers are increasingly adopting AI companions because they fill critical gaps in care delivery. Their constant availability and scalability enhance patient experience and outcomes by offering emotional support, cognitive clarity, and trusted advice whenever patients need it most. While AI companions are not new, today's technology delivers measurable benefits in patient care. For example, Woebot, an AI mental health chatbot, demonstrated reductions in anxiety and depression symptoms within just two weeks. ChatGPT's current investment in HealthBench to promote health and well-being further demonstrate its promise, commitment, and potential to help even more patients. These advances illustrate how AI tools can effectively complement traditional healthcare by improving patient well-being through consistent reassurance and engagement. So, what's holding back wider reliance on chatbots? The Hindrance: Why We Can't Fully Rely on AI Chatbot Companions Despite rapid advancements, AI companions are far from flawless, especially in healthcare where the margin for error is razor thin. Large language models (LLMs) like ChatGPT and Claude are trained on vast datasets that may harbor hidden biases, potentially misleading vulnerable patient populations. Even with impressive capabilities, ChatGPT can still hallucinate or provide factually incorrect information—posing real risks if patients substitute AI guidance for professional medical advice. While future versions may improve reliability, current models are not suited for unsupervised clinical use. Sometimes, AI-generated recommendations may conflict with physicians' advice, which can undermine trust and disrupt the patient–clinician relationship. There is also a risk of patients forming deep emotional bonds with AI, leading to over-dependence and blurred boundaries between digital and human interaction. As LinkedIn cofounder Reid Hoffman put it in Business Insider, 'I don't think any AI tool today is capable of being a friend,' and "And I think if it's pretending to be a friend, you're actually harming the person in so doing." For now, AI companions should be regarded as valuable complements to human expertise, empathy, and accountability — not replacements. A Balanced, Safe Framework: Maximizing Benefit, Minimizing Risk To harness AI companions' full potential while minimizing risks, a robust framework is essential. This begins with data transparency and governance: models must be trained on inclusive, high-quality datasets designed to reduce demographic bias and errors. Clinical alignment is critical; AI systems should be trained on evidence-based protocols and guidelines, with a clear distinction between educational information and personalized medical advice. Reliability and ethical safeguards are vital, including break prompts during extended interactions, guidance directing users to seek human support when needed, and transparent communication about AI's limitations. Above all, AI should complement human clinicians, acting as a navigator or translator to encourage and facilitate open dialogue between patients and their healthcare providers. Executive Call to Action In today's digital age, patients inevitably turn to the internet and increasingly to AI chatbots like ChatGPT and Claude for answers and reassurance. Attempts to restrict this behavior are neither practical nor beneficial. Executive physician advisors and healthcare leaders are therefore responsible for embracing this reality by providing structured, transparent, and integrated pathways that guide patients in using these powerful tools wisely. It is critical that healthcare systems are equipped with frameworks ensuring AI complements clinical care rather than confuses or replaces it. Where AI capabilities fall short, these gaps must be bridged with human expertise and ethical oversight. Innovation should never come at the expense of patient safety, trust, or quality of care. By proactively shaping AI deployment in healthcare, stakeholders can empower patients with reliable information, foster meaningful clinician-patient dialogue, and ultimately improve outcomes in this new era of AI-driven medicine.
Yahoo
an hour ago
- Yahoo
Atlanta police officer dies after shooting near CDC headquarters
A police officer has died from injuries sustained while responding to a shooting outside the headquarters of the US Centers for Disease Control and Prevention (CDC) in Atlanta. The incident, which took place on Friday near Emory University, involved a "single shooter" who is now dead, the Atlanta police department said. It said the officer, David Rose, had been taken to hospital and later died from his injuries. No civilian was wounded in the incident. The motive is unclear, but US media, citing an unnamed law-enforcement official, reported a theory that the gunman believed he was sick as a result of a coronavirus vaccine. Media reports also suggested the man's father had called police on the day of the shooting believing his son was suicidal. CDC Director Susan Monarez said the centre was "heartbroken" by the attack. "DeKalb County police, CDC security, and Emory University responded immediately and decisively, helping to prevent further harm to our staff and community," she wrote in a post on X. In a press briefing on Friday, police said they became aware of a report of an active shooter at around 16:50 local time (21:50 BST) near the CDC campus. Officers from multiple agencies responded. Emory University posted at the time on social media: "Active shooter on Emory Atlanta Campus at Emory Point CVS. RUN, HIDE, FIGHT." The CDC campus received multiple rounds of gunfire into buildings. Police said they found the shooter "struck by gunfire" - but could not specify whether that was from law enforcement or self-inflicted. Media outlets have reported that CDC employees have been asked to work remotely on Monday.
Yahoo
an hour ago
- Yahoo
Thousands of Birmingham people to benefit from projects aimed at tackling health issues
Millions of pounds will fund a number of new projects across Birmingham to help boost healthcare for thousands of people across the city. A total of £4.51 million has been allocated to fund nine projects, with grants of up to £500,000 each being handed to charities, community and health organisations. It is part of the NHS Birmingham and Solihull Integrated Care System's (BSol ICS) innovative Fairer Futures Fund. READ MORE: 24/7 mental health texting service launched to help support Birmingham and Solihull people The aim is for the projects to support the delivery Government's 10-year Health Plan and more than 27,000 people are expected to benefit. Projects will focus on areas including supporting healthy ageing, reducing levels of mental and cardiovascular ill-health and improve the lives of children and young people. Those receiving funding are: Forward Carers CIC – Mental health support programme for unpaid carers with a focus on engaging over 5,000 carers from under served communities that experience health inequalities. Midland Mencap – Working with primary care and local communities to improve uptake and quality of annual health checks for citizens with learning disabilities. FND Change CIC – Increasing local capacity to provide testing for blood borne viruses and provide a recovery pathway for individuals facing significant mental and physical health challenges linked to addiction, and blood-borne viruses, particularly Hepatitis C. BID Services – Recruiting 'Deaf Health Champions' to tackle health inequalities experienced by deaf and hard of hearing citizens. Birmingham and Solihull Mental Health NHS Foundation Trust – Developing a more culturally sensitive and effective approach to dementia diagnosis with a focus on under served communities. Midlands Medical Partnership – Delivering campaigns and developing health champions to work in communities to tackle health inequalities experienced by men of a Black Caribbean and African heritage. Murray Hall Community Trust – Developing and utilising community assets to improve mental health and wellbeing for South Asian communities. Sense, the National Deafblind and Rubella Association – Addressing the need for timely, accessible and holistic support for families of children and young people on the neurodevelopmental pathway. Witton Lodge Community Association – Delivering behavioural change interventions for citizens from under served communities with type 2 diabetes to support them through weight management and lifestyle change. The nine projects are due to launch in September 2025 and conclude in March 2028. Paul Athey, Deputy Chief Executive and Chief Finance Officer of NHS Birmingham and Solihull, said: 'Our Fairer Futures Fund provides a key opportunity for us to support the implementation of the 10-Year Health Plan and these new projects will provide access to services at a neighbourhood level, which will enhance the day-to-day lives of our communities, helping them to live healthier, happier lives.' Coun Mariam Khan, Birmingham City Council 's Cabinet Member for Health and Social Care said: 'These projects demonstrate the power of collaboration between local government, the NHS, and the voluntary and community sector. 'We are proud to support initiatives that are rooted in the communities they serve, and which tackle the health challenges people face.'
